ARTICLE | Clinical News
Glatiramer acetate regulatory update
July 14, 2008 7:00 AM UTC
FDA accepted for review an ANDA from Momenta partner Sandoz for a generic version of glatiramer. Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA; Jerusalem, Israel) markets Copaxone glatiramer to t...